RAND Conference and Webcast on Public Health Regulations for Marijuana
On February 11, 2013, the RAND Drug Policy Research Center presented a program on Developing Public Health Regulations for Marijuana: Lessons from Alcohol and Tobacco at the RAND offices in Washington D.C.
The program was recorded by C-SPAN and can be viewed at http://www.c-spanvideo.org/program/310927-2
About the Program
With Colorado and Washington both passing initiatives to legalize the commercial production, distribution, and possession of marijuana for non-medical purposes, policymakers at the local, state, and federal levels now face questions that have never been addressed. To help leaders better understand the possible consequences of these decisions, the RAND Drug Policy Research Center will convene a session focused on issues surrounding the development of public health regulations for marijuana.
The purpose of this conference is not to address whether passage of these state initiatives was good or bad or whether the federal government should intervene; rather, it will focus on raising awareness of the multitude of regulatory issues facing agencies trying to design a comprehensive policy. There will be a special focus on how different alcohol and tobacco regulations (e.g., licensing, advertising restrictions, user/sales restrictions) influence youth access and minimize public health harms.
Welcome & Introduction
Panel A: Licensing/Production/Distribution
Panel B: Restrictions on Use/Sales/Advertising
Speakers and Presentation Slides
Rebecca Collins, Senior Behavioral Scientist at RAND and Director of RAND's Health Promotion and Disease Prevention Program
Jill Lamoureux, Program Director at Americans for Safe Access, which was awarded the contract by the Washington D.C. Department of Health to train medical marijuana cultivators and distributors. View slides
Rosalie Liccardo Pacula, Senior Economist at RAND, Co-Director of RAND's Drug Policy Research Center, and Acting Director of RAND Health's Economics, Finance, and Organization Program. View slides (co-presented with Beau Kilmer)
Alexander Wagenaar, Professor of Health Outcomes and Policy at University of Florida and Associate Director of the Public Health Law Research Program at Temple University. View slides: Panel A and Panel B
The views presented in the above presentations are those of the speakers and do not necessarily represent those of RAND or the RAND Drug Policy Research Center
About the RAND Drug Policy Research Center
Since 1989, the RAND Drug Policy Research Center has conducted research to help decisionmakers in the United States and throughout the world address issues involving alcohol and other drugs. In doing so, the Center brings an objective and data-driven perspective to this often emotional and fractious policy arena. For more information about RAND's research on marijuana and marijuana policy, please click here.